VanEck Biotech ETF
BBH
113 hedge funds and large institutions have $151M invested in VanEck Biotech ETF in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 13 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 20
0.39% more ownership
Funds ownership: 33.09% → 33.48% (+0.39%)
5% less capital invested
Capital invested by funds: $159M → $151M (-$7.16M)
8% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 13
3% less funds holding
Funds holding: 116 → 113 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$3.74M |
| 2 |
Jane Street
New York
|
+$1.58M |
| 3 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$953K |
| 4 |
Morgan Stanley
New York
|
+$878K |
| 5 |
LPL Financial
San Diego,
California
|
+$582K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$9.91M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.13M |
| 3 |
FFN
Focus Financial Network
Minneapolis,
Minnesota
|
-$2.33M |
| 4 |
ACA
Atlas Capital Advisors
Jackson,
Wyoming
|
-$942K |
| 5 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
-$800K |
BBH Hedge Fund Activity: Q1 2024 in Review
113 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2024, worth a combined $151M — down 4.5% from $159M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of BBH and 12 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 32 added.
The largest buyer was Northwestern Mutual Wealth Management, adding an estimated $3.74M. The largest seller was Bank of America, cutting an estimated $9.91M.
- 113 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2024, down from 116 in Q4 2023.
- Funds reported $151M of VanEck Biotech ETF stock for Q1 2024, down 4.5% quarter-over-quarter.
- 12 funds opened new VanEck Biotech ETF positions in Q1 2024 and 13 closed out, a net change of -1 holder.
- The largest VanEck Biotech ETF buyer in Q1 2024 was Northwestern Mutual Wealth Management, an estimated $3.74M added.
- The largest VanEck Biotech ETF seller in Q1 2024 was Bank of America, an estimated $9.91M sold.
Based on aggregated 13F filings for Q1 2024.